Skip to main content
. 2023 Mar 22;10(3):1871–1882. doi: 10.1002/ehf2.14350

TABLE 3.

Quality of life measures

All patients (N = 169)
KCCQ: domain scores
Physical limitation a 66.2 ± 24.1
Symptom stability b 46.9 ± 15.0
Symptom frequency b 60.5 ± 26.0
Symptom burden b 68.0 ± 22.0
Self‐efficacy b 74.6 ± 23.2
Quality of life b 62.2 ± 24.6
Social limitation c 67.1 ± 24.9
KCCQ: summary scores
Total symptom score b 64.3 ± 23.1
<50 47 (27.8)
50–75 63 (37.3)
>75 58 (34.3)
Overall summary score 64.8 ± 20.9
<50 43 (25.4)
50–75 67 (39.6)
>75 59 (34.9)
Clinical summary score 65.1 ± 21.5
<50 42 (24.9)
50–75 65 (38.5)
>75 62 (36.7)
EQ‐5D‐5L utility scores
Mobility 1.2 ± 1.1
Self‐care 0.4 ± 0.7
Usual activities 1.2 ± 1.1
Pain/discomfort 1.0 ± 1.0
Anxiety/depression 0.6 ± 0.8
Total score 0.8 ± 0.2
EQ‐5D‐5L VAS
Your health today 62.9 ± 20.6
<50 36 (21.3)
50–75 77 (45.6)
>75 54 (32.0)
MDI rating scale
No depression 151 (89.3)
Mild depression 5 (3.0)
Moderate depression 6 (3.6)
Severe depression 7 (4.1)

Data are presented as mean ± SD or n (%).

KCCQ, Kansas City Cardiomyopathy Questionnaire; MDI, Major Depression Inventory; VAS, Visual Analog Scale.

a

Based on 167 patients.

b

Based on 168 patients.

c

Based on 165 patients.